ABD merkezli Milken Enstitüsü Covid-19 tedavisinde gelişmeleri izlemek için Tedavi takipçisi/işlemcisini uygulamaya koymuştur.
Tedavide 16 ilaç ve aşı çalışmalarında 9 alternatifin gelişmeleri izlenmektedir.
Aşı çalışmalarında ABD-Moderna ilaç şirketiyle Çin -Cansino Biologics klinik çalışma fazına gelmişlerdir.
The US-based Milken Institute has launched a COVID-19 treatment and vaccine tracker, which has identified 16 new treatments in the pipeline along with nine new vaccine candidates since launching a week ago.
Two potential vaccines have advanced to clinical trials. They are being developed by US-based Moderna and China’s CanSino Biologics. In addition, the World Health Organization announced the global SOLIDARITY trial to develop treatments for the disease.
In total, the Milken Institute is now tracking 71 treatments and 47 vaccines in development. Treatments are grouped into candidate categories, including antibodies, antivirals, cell-based therapies, among others.
The COVID-19 Treatment and Vaccine Tracker is produced and maintained by FasterCures, a centre of the Milken Institute, with an Advisory Council comprised of three former FDA chiefs, a Nobel Laureate biologist, and key industry leaders.